DJIA 17,810.06 91.06 0.51%
NASDAQ 4,712.97 11.10 0.24%
S&P 500 2,063.50 10.75 0.52%
market minute promo

0.72 -0.01 (-1.37%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

NBY $0.72 -1.37%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $0.74
Previous Close $0.73
Daily Range $0.71 - $0.74
52-Week Range $0.69 - $1.48
Market Cap $37.2M
P/E Ratio -2.28
Dividend (Yield) $0.00 (0.0%)
Volume 94,230
Average Daily Volume 127,118
Current FY EPS $0.00

Sector

Healthcare

Industry

Drugs

NOVABAY PHARMACEUTICALS, INC. (NBY) Description

NovaBay Pharmaceuticals Inc. is a clinical stage pharmaceutical Company engaged in the discovery and development of innovative product candidates for the treatment or prevention of a range of infections in hospital and non-hospital environments. Website: http://www.novabaypharma.com/

News & Commentary

Avoid This Drug Stock

NovaBay Pharmaceuticals Receives 2nd Major NeutroPhase Order For 150,000 Units From China Pioneer Ph

NovaBay Pharmaceuticals Receives 2nd Major NeutroPhase Order For 150,000 Units From China Pioneer Pharma

NovaBay Reports Receiving of First Large NeutroPhase Order

Week In Review: DXY Receives $70 Million Investment From Tencent

Sector Update: Health-Care Shares Flat Pre-Market

Sector Update: Health Care

China's FDA Cleares NovaBay's NeutroPhase Skin And Wound Cleanser For Sale Throughout Mainland China

China's FDA Cleares NovaBay's NeutroPhase Skin And Wound Cleanser For Sale Throughout Mainland China By NovaBay's Partner, China Pioneer Pharma

Why NovaBay Pharmaceuticals (NBY) Stock Plummeted to a One-Year Low Today

Morning Market Losers

Behind The Promotion Of Northwest Bio

Stocks: Larry Feinberg Buys at Accelerate Diagnostics, China Pioneer Pharma Buys at NovaBay

Plus, purchases at Boulder Brands and Noble.

See More NBY News...

NBY's Top Competitors

NBY $0.72 (-1.37%)
Current stock: NBY
JNJ $107.86 (0.35%)
Current stock: JNJ
PFE $30.45 (0.03%)
Current stock: PFE
RHHBY $37.33 (-0.93%)
Current stock: RHHBY